Paper19908158
Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells.
Biswal BK and 3 others. Cytotechnology, 2009. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells. Papers, record 19908158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19908158
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16290254 | Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. | Adv Drug Deliv Rev | 2005 | https://conductscience.org/library/papers/16290254 | PubMed |
| 2 | 16536456 | Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. | Bioconjug Chem | 2006 | https://conductscience.org/library/papers/16536456 | PubMed |
| 3 | 16161993 | Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. | J Med Chem | 2005 | https://conductscience.org/library/papers/16161993 | PubMed |
| 4 | 15237975 | Strong blue photoluminescence and ECL from OH-terminated PAMAM dendrimers in the absence of gold nanoparticles. | J Am Chem Soc | 2004 | https://conductscience.org/library/papers/15237975 | PubMed |
| 5 | 17379171 | A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells. | Nanomedicine | 2007 | https://conductscience.org/library/papers/17379171 | PubMed |
| 6 | 15664513 | Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. | Chem Biol | 2005 | https://conductscience.org/library/papers/15664513 | PubMed |
| 7 | 16099117 | Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. | Int J Pharm | 2005 | https://conductscience.org/library/papers/16099117 | PubMed |
| 8 | 16357150 | ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. | Cancer Res | 2005 | https://conductscience.org/library/papers/16357150 | PubMed |
| 9 | 16686365 | P-glycoprotein recognition of substrates and circumvention through rational drug design. | Mol Pharm | 2006 | https://conductscience.org/library/papers/16686365 | PubMed |
| 10 | 11379779 | Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine. | Biol Pharm Bull | 2001 | https://conductscience.org/library/papers/11379779 | PubMed |
| 11 | 15916424 | Targeting and inhibition of cell growth by an engineered dendritic nanodevice. | J Med Chem | 2005 | https://conductscience.org/library/papers/15916424 | PubMed |
| 12 | 11301287 | Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. | Drug Discov Today | 2001 | https://conductscience.org/library/papers/11301287 | PubMed |
| 13 | 15023456 | The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. | J Control Release | 2004 | https://conductscience.org/library/papers/15023456 | PubMed |
| 14 | 16310283 | Dendrimer-drug interactions. | Adv Drug Deliv Rev | 2005 | https://conductscience.org/library/papers/16310283 | PubMed |
| 15 | 15676297 | Dendrimers and dendritic polymers in drug delivery. | Drug Discov Today | 2005 | https://conductscience.org/library/papers/15676297 | PubMed |
| 16 | 15479057 | Fluorescence emission from dendrimers and its pH dependence. | J Am Chem Soc | 2004 | https://conductscience.org/library/papers/15479057 | PubMed |
| 17 | 17123539 | Fluorescence emission from PAMAM and PPI dendrimers. | J Colloid Interface Sci | 2007 | https://conductscience.org/library/papers/17123539 | PubMed |
| 18 | 17188439 | In vitro evaluation of dendrimer prodrugs for oral drug delivery. | Int J Pharm | 2007 | https://conductscience.org/library/papers/17188439 | PubMed |
| 19 | 10699285 | Oral uptake and translocation of a polylysine dendrimer with a lipid surface. | J Control Release | 2000 | https://conductscience.org/library/papers/10699285 | PubMed |
| 20 | 9506530 | Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. | Int J Cancer | 1998 | https://conductscience.org/library/papers/9506530 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 38257672 | Surface-Plasmon-Resonance Amplification of FMD Detection through Dendrimer Conjugation. | Sensors (Basel) | 2024 | https://conductscience.org/library/papers/38257672 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19908158
GET https://conductscience.org/api/papers/v1/19908158/references?page=2